XLO — Xilio Therapeutics Share News
0.000.00%
Last trade - 00:00- $49.81m
- -$86.23m
- $43.77m
Brief: Xilio Therapeutics Reports Pipeline And Business Highlights And First Quarter 2022 Financial Results
NASDAQ RESUMED AT 12:32 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:22 PM
Brief: Xilio Therapeutics Reports Pipeline And Business Progress And Fourth Quarter And Full Year 2021 Financial Results
Brief: Xilio Therapeutics Announces Initiation Of Patient Dosing In Phase 1/2 Clinical Trial Of XTX202
Brief: Xilio Therapeutics Reports Pipeline And Business Progress And Third Quarter 2021 Financial Results
Brief: Xilio Therapeutics Reports Preclinical Data Of XTX301 In Cancer Annual Meeting
Brief: Xilio Therapeutics Announces Closing Of Initial Public Offering
Brief: Xilio Therapeutics Shares Open 6.3% Below IPO Price In Nasdaq Debut
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:43 AM
NASDAQ RESUMED AT 09:43 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:38 AM
NASDAQ RESUMED AT 09:37 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
Brief: Xilio Therapeutics Announced Pricing Of Its Initial Public Offering